{"slug":"device","tag":"device","variants":["device"],"description":"No description yet","count":2,"kinds":{"trial":1,"technology":1},"related":[{"slug":"alpha-emitter","tag":"alpha-emitter","shared":1},{"slug":"interim","tag":"interim","shared":1},{"slug":"single-arm","tag":"single-arm","shared":1},{"slug":"sponsor-reported","tag":"sponsor-reported","shared":1}],"records":[{"id":"regain-alpha-dart","kind":"trial","name":"REGAIN (Alpha DaRT in recurrent glioblastoma)","route":"/trials/regain-alpha-dart/","status":"recruiting","tldr":"A small early study of tiny radioactive sources placed inside glioblastoma that has come back. By November 2026 eight people had been treated and all were alive; the tumour had shrunk or disappeared on scans in the six assessed so far. There is no comparison group, follow-up is short, and half of the responses still need a confirming scan."},{"id":"diffusing-alpha-emitter-radiotherapy","kind":"technology","name":"Diffusing alpha-emitter radiation therapy (Alpha DaRT)","route":"/technologies/diffusing-alpha-emitter-radiotherapy/","status":"emerging","tldr":"Thin metal sources carrying radium-224 are placed inside a solid tumour. As the radium decays, short-lived radioactive atoms leave the source, spread a few millimetres through the tumour and give off alpha particles, a radiation that does heavy damage over a very short distance. The human evidence so far is small studies with no comparison group."}]}